Reply to Gurgul-Convey and Lenzen: Cytokines, nitric oxide, and β-cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

1 citing paper in PubMed.

1. Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associated.Cell and tissue research · 2021
   Article

Corrections and comments

• Comment on
  How the location of superoxide generation influences the β-cell response to nitric oxide.2015
• Comment on
  Is nitric oxide really the primary mediator of pancreatic β-cell death in type 1 diabetes?2015

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as